Fuda Xie, Bonan Chen, Xiaoli Liu, Jun Yu, Ka Fai To, & Wei Kang. (2022). Cyclin‐dependent kinase 12‐mediated super‐enhancers as promising targets in cancer therapy. Wiley.
Chicago Style (17th ed.) CitationFuda Xie, Bonan Chen, Xiaoli Liu, Jun Yu, Ka Fai To, and Wei Kang. Cyclin‐dependent Kinase 12‐mediated Super‐enhancers as Promising Targets in Cancer Therapy. Wiley, 2022.
MLA (9th ed.) CitationFuda Xie, et al. Cyclin‐dependent Kinase 12‐mediated Super‐enhancers as Promising Targets in Cancer Therapy. Wiley, 2022.
Warning: These citations may not always be 100% accurate.